Integra LifeSciences Introduces InterFix Radiosurgery Kit for Use With TomoTherapy Radiation Treatment Systems

PLAINSBORO, N.J., Feb. 28, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings
Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, Inc.,
has launched the InterFix(TM) Radiosurgery Kit for use with TomoTherapy(R) radiation
treatment systems. The InterFix(TM) Radiosurgery Kit provides a way to adapt the
existing Integra Radionics(TM) stereotactic hardware to the TomoTherapy(R) Hi-Art(R)
system for stereotactic treatment of cranial tumors and vascular malformations. The
InterFix(TM) Radiosurgery Kit has received FDA clearance in the United States, as well as
CE Mark Certification in the European Union.

Integra Radionics has a long history in stereotactic surgery, with the CRW(TM) stereotactic
system for neurosurgery, and the XKnife(TM) system for stereotactic radiosurgery. Its
research and development team worked extensively with TomoTherapy to develop a means
to utilize the industry-leading Radionics(TM) stereotactic tools with the Hi-Art(TM) treatment system

source: Prime Newswire